Puquitinib, a novel orally available PI3Kδ inhibitor, exhibits potent antitumor efficacy against acute myeloid leukemia

Por Xie, Chengying, He, Ye, Zhen, Mingyue, Wang, Yulan, Xu, Yongping, Lou, Liguang
Publicado no Cancer Sci (2017)